Abstract:IntroductionMounting evidence in the past have substantiated the role of long‐non coding RNAs (lncRNAs) in diabetic cardiomyopathy (DCM). However, the pathogenesis of DCM remains unknown.AimThis study aimed to investigate the effect of the pro‐diabetic stimulus on the profile of lncRNAs and mRNAs, and the underlying co‐expression signaling network associated with DCM disease pathogenesis.ResultsOut of 40,173 lncRNAs and 20,730 mRNAs being screened, 1582 mRNAs and 2046 lncRNAs were differentially regulated (fold change>2.0, P<0.05) between DCM and control group of which more than half were intergenic and antisense lncRNAs. The subgroup analysis revealed more than 411 lncRNAs being co‐expressed with neighboring genes. To further investigate the potential regulatory role of these lncRNAs in gene regulation and the pathogenesis of DCM we constructed lncRNA‐mRNA co‐expression network which showed overall 48,155 significant co‐expression network connections. Moreover, in the DCM derived network, we had a comparatively greater number of nodes and connections than that in the control group. Majority of the dysregulated mRNAs of DCM co‐expression network were significantly enriched for the GO terms including actomyosin structure organization (GO:0031032), muscle contraction (GO:0006936), membrane raft assembly (GO:0001765), drinking behavior (GO:0042756), Focal adhesion (GO:0005925), skeletal muscle tissue development (GO:0007519), and cell‐matrix adhesion (GO:0007160) which have been associated with DCM in the past.ConclusionThis is the first study to investigate the genome‐wide lncRNA expression profile and co‐expression patterns with mRNA in DCM using microarray technology. These results provide comprehensive data about the pathways and regulatory mechanisms associated with DCM and indicate that lncRNAs may play a crucial role in DCM.Support or Funding InformationThis work was supported, in part, by a National Institutes of Health research grant P01GM 066730 (to Dr. Bosnjak) from the United States Public Health Services, Bethesda, Maryland, USA & DST‐UKEIRI DST/INT/UK/P‐50/2012 (to Dr. Anuradha Dhanasekaran) from the Department of Science and Technology, New Delhi, India.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Long Noncoding RNAs: A New Player in the Prevention and Treatment of Diabetic Cardiomyopathy?

Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis

Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy

Current Status and Strategies of Long Noncoding RNA Research for Diabetic Cardiomyopathy

Unveiling the Vital Role of Long Non-Coding RNAs in Cardiac Oxidative Stress, Cell Death, and Fibrosis in Diabetic Cardiomyopathy

RNA Sequencing of Cardiac in a Rat Model Uncovers Potential Target LncRNA of Diabetic Cardiomyopathy

Analysis of Changes in Circular RNA Expression and Construction of Cerna Networks in Human Dilated Cardiomyopathy.

Roles of non-coding RNA in diabetic cardiomyopathy

Differential Expression Profiles of Transfer RNA-Derived Small RNAs and Their Potential Roles in Diabetic Cardiomyopathy

Co‐expression Network Analysis of Altered Lncrnas and Mrnas in Diabetic Cardiomyopathy Using Human Ipsc‐derived Cardiomyocytes

Distinct Circulating Expression Profiles of Long Noncoding RNAs in Heart Failure Patients with Ischemic and Nonischemic Dilated Cardiomyopathy.

Diabetic Cardiomyopathy: the Role of Micrornas and Long Non-Coding RNAs

LncRNA and mRNA expression characteristic and bioinformatic analysis in myocardium of diabetic cardiomyopathy mice

Non-coding RNA-mediated endothelial-to-mesenchymal transition in human diabetic cardiomyopathy, potential regulation by DNA methylation

MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics

Genome-wide Differential Expression Profiling of Lncrnas and Mrnas Associated with Early Diabetic Cardiomyopathy

Microarray Analysis Of Long Non-Coding Rna And Mrna Expression Profiles In Diabetic Cardiomyopathy Using Human Ipscs-Derived Cardiomyocytes.

LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy

Non‐coding RNA involvement in the pathogenesis of diabetic cardiomyopathy

The interregulatory circuit between non-coding RNA and apoptotic signaling in diabetic cardiomyopathy

The Roles of Long Noncoding RNAs in Myocardial Pathophysiology